Eye Doctors in Royal Oak, MI
Welcome to Pearle Vision Royal Oak. ORDER YOUR CONTACT LENSES ONLINE AT - YOURLENS.COM/PVROYALOAK Our eyeglass store and vision center is dedicated to providing you with the best in vision care by our eye doctors and the latest prescription sunglasses, eyeglasses, contacts and designer eyewear. For over 35 years, we have been serving Royal Oak, Huntington Woods, Berkley, Birmingham, Clawson, Troy, Pleasant Ridge, Bloomfield Hills, Southfield, Madison Heights and Detroit and Oakland and Wayne Counties. Our on-site "state of the art" digital lens manufacturing equipment provides the best optics of eyeglass lens production. Make sure you are seeing your best by scheduling an eye exam at Pearle Vision of Royal Oak today! Select Sunday hours available. Please contact the store for details or book your appointment online.
Store info
32987 Woodward Ave, Royal Oak, MI 48073
- 248-549-9080
Store Hours
| Sun | 9:00 AM - 2:00 PM |
| Mon | 9:00 AM - 6:00 PM |
| Tue | 9:00 AM - 6:00 PM |
| Wed | 9:00 AM - 6:00 PM |
| Thu | 9:00 AM - 6:00 PM |
| Fri | 9:00 AM - 5:00 PM |
| Sat | 9:00 AM - 4:00 PM |
Accepted Insurances
We work with most major health and vision plans.
40% off lenses with frame purchase
Print or show in store to redeem.
Save 40% on lenses with frame purchase. Complete pair (frame and lenses) purchase required. Valid prescription required.
Terms & conditions apply

40% off second pair
Print or show in store to redeem.
Buy a complete pair of eyeglasses or prescription sunglasses (frame and lenses) and get a second pair (same prescription, same day) for up to 40% off.
Terms & conditions applyLearn More
Where to Buy Glasses
Discover MoreHow to Choose an Eye Doctor
Discover MoreHow to Tell if Your Child Needs Glasses
Discover MoreDiscover New Styles
ESSILOR® STELLEST® LENSES
Essilor® Stellest® lenses are the first and only FDA market authorized spectacle lens to slow the progression of nearsightedness in children
*Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6-12 years at initiation of treatment.

















